Paper34689986
Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.
Masouros P and 2 others. Injury, 2022. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials. Papers, record 34689986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34689986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifibrinolytic Agents | Major topic |
| Hip Fractures | Major topic |
| Tranexamic Acid | Major topic |
| Aged | |
| Blood Loss, Surgical | |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07432737 | One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures | Results |
Source ClinicalTrials.gov
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795921 | Efficacy of Tranexamic Acid in a Large Population with Proximal Femur Fractures-A Matched Pair Study of 7394 Patients from the Registry for Geriatric Trauma (ATR-DGU). | J Clin Med | 2026 | https://conductscience.org/library/papers/42795921 | PubMed |
| 42445619 | Perioperative Anemia and Transfusion Management in Older Adults with Osteoporotic Hip Fractures: A Narrative Review of Current Evidence and Emerging Strategies. | Clin Interv Aging | 2026 | https://conductscience.org/library/papers/42445619 | PubMed |
| 41900860 | Tranexamic Acid for Reduction of Blood Loss in Patients with Extracapsular Proximal Femur Fractures: Systematic Review and Meta-Analysis of Randomized Clinical Trials. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900860 | PubMed |
| 40192873 | Efficacy and safety of Tranexamic acid use on postoperative blood transfusion in hip fracture patients- a systematic review and meta-analysis. | Eur J Trauma Emerg Surg | 2025 | https://conductscience.org/library/papers/40192873 | PubMed |
| 39912079 | Efficacy and Safety of Topical Tranexamic Acid in Elderly Hip Fractures Undergoing Surgical Treatment: Meta-Analysis of Randomized Controlled Trials. | Clin Orthop Surg | 2025 | https://conductscience.org/library/papers/39912079 | PubMed |
| 39247301 | Bibliometric and visualized analysis on hip fracture surgery and venous thromboembolism. | Heliyon | 2024 | https://conductscience.org/library/papers/39247301 | PubMed |
| 38831387 | A systematic review and meta-analysis of systematic and topical tranexamic acid administration in aesthetic plastic surgery. | Perioper Med (Lond) | 2024 | https://conductscience.org/library/papers/38831387 | PubMed |
| 38213943 | Effectiveness of Tranexamic Acid in Trauma Patients: A Systematic Review. | Cureus | 2024 | https://conductscience.org/library/papers/38213943 | PubMed |
| 37501145 | Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis. | BMC Musculoskelet Disord | 2023 | https://conductscience.org/library/papers/37501145 | PubMed |
| 37294864 | Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37294864 | PubMed |
| 37272509 | Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37272509 | PubMed |
| 36826487 | General Anesthesia Versus Regional Anesthesia in the Elderly Patients Undergoing Hip Fracture Surgeries: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. | World J Surg | 2023 | https://conductscience.org/library/papers/36826487 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| TRANEXAMIC ACID | CHEMBL877 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL877 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34689986
GET https://conductscience.org/api/papers/v1/34689986/authors